Business Context and Reporting Period
This Form 8-K filing by Bridgford Foods Corporation covers the period ending February 1, 2017. The report addresses a corporate governance issue regarding the independence of a board member and the resulting non-compliance with Nasdaq listing standards.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and listing status rather than financial performance.
Material Changes
- Director Independence: On February 1, 2017, the Company notified Nasdaq that Director Keith A. Ross received consulting fees, rendering him ineligible to serve as an independent director.
- Audit Committee Resignation: On February 6, 2017, Mr. Ross resigned from the Audit Committee. He remains a member of the Board of Directors.
- Regulatory Status: On February 8, 2017, Nasdaq issued a notice of noncompliance regarding the failure to maintain a compliant Audit Committee under Listing Rule 5605.
Outlook, Risks, and Management Commentary
The Company intends to regain compliance with Nasdaq rules by appointing Paul R. Zippwald to the Board and the Audit Committee. This appointment is contingent upon his election by shareholders at the 2017 Annual Meeting scheduled for March 8, 2017. The Company has been granted a cure period until March 9, 2017. Management stated that Mr. Ross's resignation was not related to any disagreement with the Company regarding operations, policies, or practices.
Investor Verification Checklist
- Verify the outcome of the shareholder vote for Paul R. Zippwald at the March 8, 2017 Annual Meeting.
- Confirm whether the Company successfully regained Nasdaq compliance by the March 9, 2017 deadline.
- Review the nature of the consulting fees paid to Keith A. Ross to understand the independence determination.